Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication. - Pindwarawala M; Bose S; Brunham LR (JACC. Case reports, 2025)